Cancer Epigenetics and Nanomedicine 1st Edition

Cancer Epigenetics and Nanomedicine, 1st Edition by Prashant Kesharwani and Chitra Thakur offers a compelling fusion of two rapidly evolving fields—epigenetics and nanotechnology—designed to redefine cancer diagnosis and therapy.

Discover how aberrant DNA methylation, histone modifications, and non-coding RNAs drive tumor progression, then see how cutting-edge nanomedicine platforms are engineered to target those changes with precision. This authoritative volume walks readers from fundamental mechanisms to translational strategies, covering targeted drug delivery, nanoparticle-based epigenetic modulators, biomarker-driven diagnostics, and the challenges of clinical translation. Richly referenced and clearly explained, it bridges molecular biology, materials science, and clinical oncology.

Ideal for oncologists, translational researchers, pharmaceutical scientists, and advanced students, this 1st Edition equips practitioners across North America, Europe, Asia and beyond with practical perspectives on designing epigenetic therapies and nanocarriers for real-world healthcare settings. Learn about safety, regulatory considerations, and case studies that illuminate pathways from bench to bedside.

If you’re seeking an integrated, future-facing resource on cancer epigenetics and nanomedicine, this book provides actionable insights and scientific depth without sacrificing readability. Enhance your research, inform clinical strategy, or deepen classroom teaching with a text that speaks to the global oncology community.

Order your copy today to stay at the forefront of targeted cancer therapy innovation and translate epigenetic knowledge into smarter, more effective nanomedicine solutions.

Note: eBooks do not include supplementary materials such as CDs, access codes, etc.